ChEMBL 32 is released!

We are pleased to announce the release of ChEMBL 32! This release of ChEMBL comes with a complete update of drug and clinical candidate information, the addition on a Natural Product likeness score and a harmonization of Journal Name abbreviations according to NLM standards.

This version of the database, prepared on 26/01/2023 contains:

2,354,965 compounds (of which 2,327,928 have mol files)
2,995,433 compound records (non-unique compounds)
20,038,828 activities
1,536,903 assays
15,139 targets
86,364 documents

Please see ChEMBL 32 release notes for full details of all changes in this release. Data can be downloaded from the ChEMBL FTP site.

Please note that on demand Oracle 19c dumps will not be provided anymore after the ChEMBL 34 release.

New Deposited Datasets

CHEMBL5058649 - Data for DCP probe BAY 1816032*
CHEMBL5058643 - Data for DCP probe BI-2081*
CHEMBL5058646 - Data for DCP probe CCT369260*
CHEMBL5058644 - Data for DCP probe JNJ-39758979*
CHEMBL5058645 - Data for DCP probe JNJ-6204*
CHEMBL5058647 - Data for DCP probe JNJ-9350*
CHEMBL5058648 - Data for DCP probe SAFit2*
CHEMBL5058641 - Data for DCP probe TP-050*
CHEMBL5058642 - Data for DCP probe TP-051*
CHEMBL5060014 - EUbOPEN Chemogenomics Library wave 2 - DSF
CHEMBL5069381 - ITC assay results for EUbOPEN Chemical Probe Library
CHEMBL5095002 - International Nonproprietary Names for Pharmaceutical Substances (INN)
CHEMBL5058564 - Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library 2 (Incuyte)
CHEMBL5058577 - Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library 2 (Multiplex)
CHEMBL5058541 - Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library 2 (NanoBRET)

* = All part of the Donated Chemical Probes source

New Sources

International Nonproprietary Names

Updated Sources

Scientific Literature (spanning publication dates from March 1974 until April 2022)
Orange Book
Clinical Candidates
Patent Bioactivity Data
USP Dictionary of USAN and International Drug Names
Prodrug active ingredients
Manually Added Drugs
Donated Chemical Probes (DCP) - SGC Frankfurt
WHO Anatomical Therapeutic Chemical Classification
Withdrawn Drugs
EUbOPEN Chemogenomic Library

Database changes since the last release

Journal names have been harmonised and standardised according to the National Library of Medicine (NLM) standards.

Tables that have been deprecated since ChEMBL 31

PROTEIN_FAMILY_CLASSIFICATION

Fields that have been deprecated since ChEMBL 31

MOLECULE_DICTIONARY.WITHDRAWN_YEAR
MOLECULE_DICTIONARY.WITHDRAWN_COUNTRY
MOLECULE_DICTIONARY.WITHDRAWN_REASON
MOLECULE_DICTIONARY.WITHDRAWN_CLASS
MOLECULE_DICTIONARY.NATURAL_PRODUCT
USAN_STEMS.WHO_EXTRA

Fields that have been added since ChEMBL 31

COMPOUND_PROPERTIES.NP_LIKENESS_SCORE
DRUG_WARNING.EFO_TERM
DRUG_WARNING.EFO_ID
DRUG_WARNING.EFO_ID_FOR_WARNING_CLASS

Field types that have been changed into FLOAT since ChEMBL 31

MOLECULE_DICTIONARY.MAX_PHASE
DRUG_INDICATION.MAX_PHASE_FOR_IND

If you require further information about ChEMBL, please contact us: chembl-help@ebi.ac.uk

To receive updates when new versions of ChEMBL are available, please sign up to our mailing list: http://listserver.ebi.ac.uk/mailman/listinfo/chembl-announce
For general queries/feedback please email: chembl-help@ebi.ac.uk
For details of upcoming webinars, please see: http://chembl.blogspot.com/search/label/Webinar

Comments

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and here for a reminder of SureChEMBL is and what it does. This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

The ChEMBL-og

Search This Blog